Target intelligence / Profile preview

Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2)

Target
ISLR2
Molecular classification
Receptor (transmembrane protein), Immunoglobulin superfamily, Leucine-rich repeat-containing protein
01

Overview

Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2), also known as LINX, is a type I transmembrane protein belonging to both the immunoglobulin superfamily and leucine-rich repeat (LRR) domain-containing proteins. ISLR2 contains five extracellular LRRs, an Ig-like domain, and a transmembrane region. It is specifically expressed in the central and peripheral nervous systems, particularly in the brain and in neurons associated with neural connectivity and axon guidance. ISLR2 is required for axon extension during neural development, contributing to the organization and connectivity of the forebrain. Deficiency or mutation of ISLR2/LINX leads to severe neurodevelopmental defects, hydrocephalus, and perinatal lethality in animal models. It is implicated in certain cancers (melanotic medulloblastoma and breast angiosarcoma). The protein shows selective neural tissue expression, with high abundance in the brain and little to no expression in non-neural cell types. While important for nervous system development, there are currently no established drugs or biomarkers directly targeting this molecule.

Other names
Immunoglobulin superfamily containing leucine-rich repeat protein 2ISLR2KIAA1465LINXUNQ1885/PRO4329leucine-rich repeat domain and immunoglobulin domain-containing axon extension proteinLeucine-rich repeat domain and immunoglobulin domain-containing axon extension protein
02

Biological functions

Axon extension and axon guidance in neural developmentCell-cell communication
03

Disease associations

Developmental neurological disorders (deficits in forebrain development, hydrocephalus, axon guidance defects)Cancer (Melanotic medulloblastoma, Breast angiosarcoma)

Beyond the preview

Go deeper on Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin superfamily containing leucine-rich repeat protein 2 (ISLR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call